Skip to content
Measles & Rubella Partnership Logo
Measles & Rubella Partnership Logo

immunizationagenda2030

  • Learn
    • Learn More
      • The Problem
      • About Us
      • Founding Partners
      • Sophie Blackall
      • Interactive Map
      • Advocacy Tools
    • The Solution
      • The Solution
      • The Strategy
      • The Vaccine
    • The Impact
      • Impact
      • Integrated Campaigns
      • Mortality Reduction
      • Routine Immunization
      • Surveillance Systems and Laboratory Network
    • Partnership Alliance
      • American Red Crossarc logo
      • IA2030
      • United Nations Foundation
      • World Health Organization
      • Unicef
      • Gavi
      • Gates Foundation
      • CDC
  • Act
    • Act
    • Donate
    • Advocacy Tools
    • Join the Discussion
    • Start a GoFundMe or Tiltify Project
  • Resources
    • More Information
      • Resources
      • Outbreaks
      • Measles and Rubella Map
      • Reports
      • Updated SOPs for the Outbreak Response Fund
    • SIA
      • SIA Schedule
    • Media
      • Video Gallery
      • Photo Gallery
      • Recent Publications
    • Tools
      • Advocacy Tools
  • M&RP news
  • Contact
X
  • Learn
    • Learn More
      • The Problem
      • About Us
      • Founding Partners
      • Sophie Blackall
      • Interactive Map
      • Advocacy Tools
    • The Solution
      • The Solution
      • The Strategy
      • The Vaccine
    • The Impact
      • Impact
      • Integrated Campaigns
      • Mortality Reduction
      • Routine Immunization
      • Surveillance Systems and Laboratory Network
    • Partnership Alliance
      • American Red Crossarc logo
      • IA2030
      • United Nations Foundation
      • World Health Organization
      • Unicef
      • Gavi
      • Gates Foundation
      • CDC
  • Act
    • Act
    • Donate
    • Advocacy Tools
    • Join the Discussion
    • Start a GoFundMe or Tiltify Project
  • Resources
    • More Information
      • Resources
      • Outbreaks
      • Measles and Rubella Map
      • Reports
      • Updated SOPs for the Outbreak Response Fund
    • SIA
      • SIA Schedule
    • Media
      • Video Gallery
      • Photo Gallery
      • Recent Publications
    • Tools
      • Advocacy Tools
  • M&RP news
  • Contact
Donate donate heart
 

Literature – Rubella

  • Home>
  • Literature – Rubella

Below are links to various articles and resources in the media about Rubella.


 

  • Rubella outbreak in a Rural Kenyan District, 2014: documenting the need for routine rubella immunization in Kenya.
    Njeru I, Onyango D, Ajack Y, Kiptoo E.
    BMC Infect Dis. 2015 Jun 27;15:245. doi: 10.1186/s12879-015-0989-6.


  • Determinants of students’ willingness to accept a measles-mumps-rubella booster vaccination during a mumps outbreak: a cross-sectional study.
    Donkers HW, Hautvast JL, Akkermans RP, Swaan CM, Ruijs WL, Hulscher ME.
    BMC Public Health. 2015 Jun 20;15:575. doi: 10.1186/s12889-015-1899-7.


  • Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.
    Leung JH, Hirai HW, Tsoi KK.
    Expert Rev Vaccines. 2015 Aug;14(8):1149-1157. Epub 2015 Jun 16.


  • Risk of febrile seizure after measles-mumps-rubella-varicella vaccine: A systematic review and meta-analysis.
    Ma SJ, Xiong YQ, Jiang LN, Chen Q.
    Vaccine. 2015 Jul 17;33(31):3636-49. doi: 10.1016/j.vaccine.2015.06.009. Epub 2015 Jun 11. Review.


  • A Socio-Demographic Examination of Adults Responding to Governmental Vaccination Recommendations during the Japanese Rubella Outbreak of 2013.
    Hori A, Wada K, Smith DR.
    PLoS One. 2015 Jun 9;10(6):e0129900. doi: 10.1371/journal.pone.0129900. eCollection 2015.


  • Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014.
    Chang C, Mo X, Hu P, Liang W, Ma H, An Z, Liu J, Zheng H.
    Vaccine. 2015 Jun 22;33(28):3223-7. doi: 10.1016/j.vaccine.2015.04.083. Epub 2015 May 16.


  • Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.
    Levine H, Zarka S, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, Balicer RD.
    Hum Vaccin Immunother. 2015 Jun 3;11(6):1400-5. doi: 10.1080/21645515.2015.1032489.


  • Vaccination coverage for measles, mumps and rubella in anthroposophical schools in Gelderland, The Netherlands.
    Klomp JH, van Lier A, Ruijs WL.
    Eur J Public Health. 2015 Jun;25(3):501-5. doi: 10.1093/eurpub/cku178. Epub 2014 Nov 17.


  • Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
    Nofal A, Nofal E, Yosef A, Nofal H.
    Int J Dermatol. 2015 Jun;54(6):667-71. doi: 10.1111/ijd.12480. Epub 2014 Jul 29.

Join our E-Newsletter

Partnership Alliance

RED CROSS IA 2030 United Nations Foundations WHO Unicef GAVI GATES Foundation CDC

The mark 'CDC' is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise. CDC's logo and work with the Partnership is not connected to any fundraising aspect of the organization.

Follow Us

Twitter Logo Twitter Logo
Measles & Rubella Partnership Logo
  • Terms & Conditions | 
  • Privacy Policy | 
  • Contact Us

© 2012 - 2025 American Red Cross

Prelude Prelude Version 2.3.2